Travere Therapeutics, Inc. · NASDAQ:TVTX
Lyons Gary A sold 10,000 Travere Therapeutics, Inc. shares (Form 4)
Traded Aug 17 to Aug 18, 2026 · Filed Aug 19, 2026
From Aug 17 to Aug 18, 2026, Lyons Gary A (Director) sold 10,000 Travere Therapeutics, Inc. shares at an average US$63.29 for US$633K under a trading plan, leaving 61,500 shares. Filed Aug 19, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$63.29 average (US$62.53 to US$64.16)
- Value
- US$633K
- Holding after
- 61,500 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Option exercise | 5,000 | US$17.44 | 66,500 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 1,900 | US$62.53 | 64,600 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 2,600 | US$63.50 | 62,000 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 500 | US$64.16 | 61,500 | Direct |
| Aug 18, 2026 | Common Stock | Option exercise | 5,000 | US$17.44 | 66,500 | Direct |
| Aug 18, 2026 | Common Stock | Sale | 4,100 | US$63.27 | 62,400 | Direct |
| Aug 18, 2026 | Common Stock | Sale | 900 | US$63.86 | 61,500 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Lyons Gary A
- Travere Therapeutics, Inc. shareholders
- Form 4 · Lyons Gary A · May 21, 2026
- Form 4 · Lyons Gary A · Apr 16, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026